These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25743322)

  • 1. Invited commentary: future of population studies--defining research priorities and processes.
    Vasan RS; Folsom AR
    Am J Epidemiol; 2015 Mar; 181(6):369-71. PubMed ID: 25743322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategic transformation of population studies: recommendations of the working group on epidemiology and population sciences from the National Heart, Lung, and Blood Advisory Council and Board of External Experts.
    Roger VL; Boerwinkle E; Crapo JD; Douglas PS; Epstein JA; Granger CB; Greenland P; Kohane I; Psaty BM
    Am J Epidemiol; 2015 Mar; 181(6):363-8. PubMed ID: 25743324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invited commentary: Evaluating epidemiologic research methods--the importance of response rate calculation.
    Harris MA
    Am J Epidemiol; 2010 Sep; 172(6):645-7; discussion 651-2. PubMed ID: 20660120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invited commentary: G-computation--lost in translation?
    Vansteelandt S; Keiding N
    Am J Epidemiol; 2011 Apr; 173(7):739-42. PubMed ID: 21415028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invited commentary: topical threats to epidemiology.
    Dunn KM
    Am J Epidemiol; 2008 Jan; 167(1):20-2; author reply 23-4. PubMed ID: 17977897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invited Commentary: Code Review-An Important Step Toward Reproducible Research.
    Platt RW
    Am J Epidemiol; 2021 Oct; 190(10):2178-2179. PubMed ID: 33834182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invited commentary: Population-based human subjects research in the era of enhanced privacy regulation.
    Ness RB
    Am J Epidemiol; 2010 Sep; 172(6):648-50; discussion 651-2. PubMed ID: 20660117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invited Commentary: The Society for Epidemiologic Research's Commitment to Diversity and Equity-Pathways to Filling the Glass.
    Ahern J; Kaufman JS; Werler MM
    Am J Epidemiol; 2021 Sep; 190(9):1727-1729. PubMed ID: 34467406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invited commentary: defining incident chronic kidney disease in epidemiologic study settings.
    Tonna SJ
    Am J Epidemiol; 2009 Aug; 170(4):425-7. PubMed ID: 19535544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roger et al. respond to "future of population studies".
    Roger VL; Boerwinkle E; Crapo JD; Douglas PS; Epstein JA; Granger CB; Greenland P; Kohane I; Psaty BM
    Am J Epidemiol; 2015 Mar; 181(6):372-3. PubMed ID: 25743323
    [No Abstract]   [Full Text] [Related]  

  • 12. Invited Commentary: When Case-Control Studies Came of Age.
    Rothman KJ
    Am J Epidemiol; 2017 Jun; 185(11):1012-1014. PubMed ID: 28535170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invited Commentary: Standards, Inputs, and Outputs-Strategies for Improving Data-Sharing and Consortia-Based Epidemiologic Research.
    Lacey JV; Benbow JL
    Am J Epidemiol; 2022 Jan; 191(1):159-162. PubMed ID: 34435200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Building bridges between populations and samples in epidemiological studies.
    Kalsbeek W; Heiss G
    Annu Rev Public Health; 2000; 21():147-69. PubMed ID: 10884950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invited commentary: consequential(ist) epidemiology: let's seize the day.
    Cates W
    Am J Epidemiol; 2013 Oct; 178(8):1192-4. PubMed ID: 24022888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement.
    Gallo V; Egger M; McCormack V; Farmer PB; Ioannidis JP; Kirsch-Volders M; Matullo G; Phillips DH; Schoket B; Stromberg U; Vermeulen R; Wild C; Porta M; Vineis P
    Eur J Clin Invest; 2012 Jan; 42(1):1-16. PubMed ID: 22023344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invited Commentary: The Continuing Need for the Sufficient Cause Model Today.
    VanderWeele TJ
    Am J Epidemiol; 2017 Jun; 185(11):1041-1043. PubMed ID: 28535245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invited Commentary: Continuing to Loosen the Constraints on Epidemiology in an Age of Change-A Comment on McMichael's "Prisoners of the Proximate".
    Galea S
    Am J Epidemiol; 2017 Jun; 185(11):1217-1219. PubMed ID: 28535291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invited commentary: the art of making questionnaires better.
    Rosen T; Olsen J
    Am J Epidemiol; 2006 Dec; 164(12):1145-9. PubMed ID: 17041133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.